Stonepine Capital Management’s AN2 Therapeutics ANTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$577K	Buy	+544,494	New	+$577K	0.57%	39
2025 Q1	–	Sell	-196,732	Closed	-$271K	–	69
2024 Q4	$271K	Buy	+196,732	New	+$271K	0.22%	45